NCT00070161View on ClinicalTrials.gov

Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 1, 2001

Primary Completion Date

May 1, 2005

Study Completion Date

August 1, 2012

Conditions
Brain and Central Nervous System TumorsRadiation Toxicity
Interventions
DIETARY_SUPPLEMENT

EGb761

DRUG

donepezil hydrochloride

PROCEDURE

cognitive assessment

Trial Locations (4)

29303

CCOP - Upstate Carolina, Spartanburg

30165

Regional Radiation Oncology Center at Rome, Rome

85006-2726

CCOP - Western Regional, Arizona, Phoenix

27157-1030

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00070161 - Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor | Biotech Hunter | Biotech Hunter